182 related articles for article (PubMed ID: 36759627)
41. Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model.
Jagga S; Sharma AR; Lee YH; Nam JS; Lee SS
Front Mol Biosci; 2021; 8():666295. PubMed ID: 34250013
[TBL] [Abstract][Full Text] [Related]
42. Aspirin inhibits osteoclast formation and wear-debris-induced bone destruction by suppressing mitogen-activated protein kinases.
Shi J; Wang Z; Guo X; Shen J; Sun H; Bai J; Yu B; Wang L; Zhou W; Liu Y; Zhang W; Yang H; Xu Y; Zhou J; Geng D
J Cell Physiol; 2020 Mar; 235(3):2599-2608. PubMed ID: 31498438
[TBL] [Abstract][Full Text] [Related]
43. Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.
Zhou CH; Shi ZL; Meng JH; Hu B; Zhao CC; Yang YT; Yu W; Chen ZX; Heng BC; Parkman VA; Jiang S; Zhu HX; Wu HB; Shen WL; Yan SG
Br J Pharmacol; 2018 Mar; 175(6):859-876. PubMed ID: 29130485
[TBL] [Abstract][Full Text] [Related]
44. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
46. Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype.
Yan Z; Tian X; Zhu J; Lu Z; Yu L; Zhang D; Liu Y; Yang C; Zhu Q; Cao X
Mol Med; 2018 May; 24(1):20. PubMed ID: 30134793
[TBL] [Abstract][Full Text] [Related]
47. Macrophage polarization in aseptic bone resorption around dental implants induced by Ti particles in a murine model.
Wang X; Li Y; Feng Y; Cheng H; Li D
J Periodontal Res; 2019 Aug; 54(4):329-338. PubMed ID: 30635919
[TBL] [Abstract][Full Text] [Related]
48. ZBTB20-mediated titanium particle-induced peri-implant osteolysis by promoting macrophage inflammatory responses.
Qiu J; Peng P; Xin M; Wen Z; Chen Z; Lin S; Kuang M; Fu Y; Fang G; Li S; Li C; Mao J; Qin L; Ding Y
Biomater Sci; 2020 Jun; 8(11):3147-3163. PubMed ID: 32363359
[TBL] [Abstract][Full Text] [Related]
49. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.
Childs LM; Paschalis EP; Xing L; Dougall WC; Anderson D; Boskey AL; Puzas JE; Rosier RN; O'Keefe RJ; Boyce BF; Schwarz EM
J Bone Miner Res; 2002 Feb; 17(2):192-9. PubMed ID: 11811549
[TBL] [Abstract][Full Text] [Related]
50. Titanium particles inhibit bone marrow mesenchymal stem cell osteogenic differentiation through the MAPK signaling pathway.
Tong S; Fang S; Ying K; Chen W
FEBS Open Bio; 2023 Sep; 13(9):1699-1708. PubMed ID: 37483149
[TBL] [Abstract][Full Text] [Related]
51. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
[TBL] [Abstract][Full Text] [Related]
52. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.
Tang W; Xiao L; Ge G; Zhong M; Zhu J; Qin J; Feng C; Zhang W; Bai J; Zhu X; Wei M; Geng D; Wang Z
J Cell Mol Med; 2020 Oct; 24(20):11972-11983. PubMed ID: 32896108
[TBL] [Abstract][Full Text] [Related]
53. Tetrandrine Inhibits Titanium Particle-Induced Inflammatory Osteolysis through the Nuclear Factor-
Liu Z; Li Y; Guo F; Zhang C; Song G; Yang J; Chen D
Mediators Inflamm; 2020; 2020():1926947. PubMed ID: 33312069
[TBL] [Abstract][Full Text] [Related]
54. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
[TBL] [Abstract][Full Text] [Related]
55. Astragaloside IV alleviates macrophage senescence and d-galactose-induced bone loss in mice through STING/NF-κB pathway.
Li M; Niu Y; Tian L; Zhang T; Zhou S; Wang L; Sun J; Wumiti T; Chen Z; Zhou Q; Ma Y; Guo Y
Int Immunopharmacol; 2024 Mar; 129():111588. PubMed ID: 38290207
[TBL] [Abstract][Full Text] [Related]
56. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
57. Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis.
Huang L; Chen W; Wei L; Su Y; Liang J; Lian H; Wang H; Long F; Yang F; Gao S; Tan Z; Xu J; Zhao J; Liu Q
Front Pharmacol; 2022; 13():848152. PubMed ID: 35300293
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss.
Zhang L; Zhang L; You H; Sun S; Liao Z; Zhao G; Chen J
Eur J Pharmacol; 2021 Aug; 904():174176. PubMed ID: 34004213
[TBL] [Abstract][Full Text] [Related]
59. Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
Liu X; Diao L; Zhang Y; Yang X; Zhou J; Mao Y; Shi X; Zhao F; Liu M
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270008
[TBL] [Abstract][Full Text] [Related]
60. Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption.
Qin A; Cheng TS; Lin Z; Cao L; Chim SM; Pavlos NJ; Xu J; Zheng MH; Dai KR
PLoS One; 2012; 7(4):e34132. PubMed ID: 22509274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
